Integra LifeSciences Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Integra LifeSciences (IART) Tops Q3 EPS by 27c
October 28, 2020 6:13 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.80, $0.27 better than the analyst estimate of $0.53. Revenue for the quarter came in at $370.2 million versus the consensus estimate of $347.98 million.
The Company's full-year 2020 guidance remains withdrawn due to the uncertainty related to COVID-19 and... More